Health

Results: 1861-1872 of 7452

PR Newswire associated0

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

Professor Katie Laird

Home washing machines fail to remove important pathogens from textiles

SciBase Expands Further Through European Market with First Sales Order to customer in Italy

Sobi Showcases Breadth of data in C3G/primary IC-MPGN at ERA 2025

Implantica announces that UK NICE has published positive recommendations for the RefluxStop™ procedure in the NHS public hospitals

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

PR Newswire associated0

Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 2025

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD

TRI Launches Major Overhaul of OPRA-CM to Unlock the Full Potential of Centralized Monitoring in Clinical Trials

Louis Denis, MD, Chief Medical Officer, Byondis

Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors